𧬠ICD-10-CM N39.41 β Urge Incontinence
Billable Code Confirmed
ICD-10-CM N39.41 is a valid, billable 5-character diagnosis code. The first three characters (N39) specify other disorders of the urinary system, the 4th character (4) indicates other specified urinary incontinence, and the 5th character (1) specifies urge incontinence. No additional characters are required.
Non-Billable Parent Codes β Never Submit These
- β
N39β 3-character header- β
N39.4β 4-character headerAlways submit N39.41 (all 5 characters) when urge incontinence is documented.
Clinical Context: Urge vs. Stress vs. Mixed
Urge incontinence involves a sudden, compelling desire to pass urine that is difficult to defer, followed by involuntary leakage. It is primarily caused by detrusor muscle overactivity. This must be distinguished from stress incontinence (N39.3), which is leakage caused by physical exertion (coughing, sneezing, lifting) due to sphincter/pelvic floor weakness. If the patient has both, you must use the combination code for mixed incontinence (N39.46).
Code Classification
ICD-10-CM Diagnosis Code β wRVU, assistant payable, and global period fields are not applicable. See CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections for associated procedural billing.
π Code Description
ICD-10-CM N39.41 classifies Urge incontinence.
Pathophysiology: Urge urinary incontinence (UUI) is predominantly caused by detrusor overactivityβinvoluntary contractions of the bladder muscle during the filling phase. This can be idiopathic or neurogenic (resulting from conditions like multiple sclerosis, stroke, or spinal cord injury). Patients experience a strong, sudden need to urinate and are often unable to reach the bathroom in time.
This condition is a core component of βOveractive Bladder (OAB) Wet.β Treatment initially involves behavioral therapies and anticholinergic or beta-3 agonist medications. Refractory cases may require advanced therapies such as intravesical botulinum toxin injections or sacral neuromodulation.
π³ Code Tree / Hierarchy
N39 Other disorders of urinary system β Non-billable
β
βββ N39.3 Stress incontinence (female) (male) β
Billable
βββ N39.4 Other specified urinary incontinence β Non-billable
β βββ N39.41 Urge incontinence β THIS CODE β
Billable
β βββ N39.42 Incontinence without sensory awareness β
Billable
β βββ N39.43 Post-void dribbling β
Billable
β βββ N39.44 Nocturnal enuresis β
Billable
β βββ N39.45 Continuous leakage β
Billable
β βββ N39.46 Mixed incontinence β
Billable
β βββ N39.490 Overflow incontinence β
Billable
β βββ N39.498 Other specified urinary incontinence β
Billable
β Includes
The following clinical terms map directly to N39.41 when documented in the medical record:
- Urge urinary incontinence (UUI)
- Overactive bladder with incontinence (OAB wet)
- Detrusor instability with incontinence
- Detrusor hyperreflexia with incontinence
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with CODE
| Code | Description | Note |
|---|---|---|
| N39.46 | Mixed incontinence | Mutually exclusive. If the patient has both urge AND stress incontinence, use the mixed code instead of coding them separately. |
| N39.3 | Stress incontinence | Mutually exclusive. Indicates leakage from physical exertion rather than detrusor spasm. |
| R32 | Unspecified urinary incontinence | Mutually exclusive. Do not use the symptom code if the specific type (urge) is known. |
π Clinical Overview
βCode Alsoβ Guideline
ICD-10-CM instructs coders to identify associated conditions when reporting codes under the N39.4 category. Most notably:
- Code also any associated overactive bladder (N32.81) if explicitly documented by the provider.
Associated Neurogenic Etiologies
If the urge incontinence is neurogenic in origin (caused by a central nervous system disorder), ensure the underlying disease is also coded to capture the full clinical complexity:
- G35.D β Multiple sclerosis
- G81.90 β Hemiplegia, unspecified
- G82.20 β Paraplegia, unspecified
- I69.398 β Other sequelae of cerebral infarction
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | β Not Mapped |
N39.41 does not map to an HCC. However, if the incontinence is a manifestation of a severe underlying neurological disorder (e.g., paraplegia or multiple sclerosis), those underlying conditions do carry significant HCC weight and must be coded and documented annually.
π₯ DRG Assignment
MDC 11 β Diseases and Disorders of the Kidney and Urinary Tract
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 698 | Other Kidney and Urinary Tract Diagnoses with MCC | ~1.60 |
| DRG 699 | Other Kidney and Urinary Tract Diagnoses with CC | ~0.95 |
| DRG 700 | Other Kidney and Urinary Tract Diagnoses without CC/MCC | ~0.70 |
Approximate. Verify against IPPS FY2026 Final Rule tables.
π οΈ Commonly Associated CPT Codes (Urology / Urogynecology)
| CPT Code | Description | Modifier Notes / wRVU |
|---|---|---|
| 99214 | Office or other outpatient visit (Moderate MDM) | Typical for evaluating treatment failure, reviewing voiding diaries, and initiating new OAB medications. |
| 51726 | Complex cystometrogram (ie, calibrated electronic equipment) | Core urodynamics test used to measure bladder capacity and document detrusor overactivity. (wRVU: ~1.20 for modifier -26) |
| 51729 | Complex cystometrogram; with voiding pressure studies | Often performed together with 51726 and bundled unless indicated otherwise. |
| 52287 | Cystourethroscopy, with injection(s) for chemo-denervation of the bladder | Injection of botulinum toxin (Botox) into the detrusor muscle for refractory urge incontinence. (wRVU: ~3.25) |
| 64561 | Percutaneous implantation of neurostimulator electrode array; sacral nerve | Stage 1 trial for sacral neuromodulation (e.g., InterStim) to treat refractory UUI. |
| 64581 | Open implantation of neurostimulator electrode array; sacral nerve | Permanent placement of the neuromodulation array. |
π Coding Scenarios and Examples
Scenario 1 β Outpatient Urology Visit
Clinical Vignette: A 65-year-old female presents to the urology clinic for follow-up of overactive bladder. She reports severe urgency followed by large-volume urine leakage occurring 3-4 times a day, which requires her to wear heavy pads. She denies leakage when coughing or sneezing. The provider reviews her voiding diary, diagnoses her with urge incontinence secondary to overactive bladder, and prescribes mirabegron (Myrbetriq).
Diagnoses:
- N39.41 β Urge incontinence (Primary specific functional complaint)
- N32.81 β Overactive bladder (Follows the βCode alsoβ guideline)
Procedure:
- 99214 β E/M established patient, Moderate MDM
Scenario 2 β Outpatient Chemodenervation (Botox)
Clinical Vignette: A 58-year-old male with a history of spinal cord injury (T10 paraplegia) suffers from severe neurogenic detrusor overactivity and refractory urge incontinence, failing multiple anticholinergic medications. He presents to the ambulatory surgery center for intravesical botulinum toxin injection. Under local anesthesia, cystoscopy is performed, and 200 units of Botox are injected into 20 sites across the detrusor muscle sparing the trigone.
Diagnoses:
- N39.41 β Urge incontinence (Symptom treated)
- N31.9 β Neuromuscular dysfunction of bladder, unspecified (Neurogenic component)
- G82.20 β Paraplegia, unspecified (Underlying etiology)
Procedures / HCPCS:
- 52287 β Cystourethroscopy, with injection(s) for chemo-denervation of the bladder
J0585x 200 β Injection, onabotulinumtoxinA, 1 unit (x 200 units)
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Using Separate Stress/Urge Codes. If a patient is diagnosed with both stress incontinence and urge incontinence, do not code N39.3 and N39.41 together. You must combine them into the single code N39.46 (Mixed incontinence). This is a frequent Excludes1 error.^1 |
| β | Defaulting to R32. Do not use R32 (Unspecified urinary incontinence) if the provider specifically documents βurge leakageβ or βUUI.β N39.41 provides much greater specificity and establishes medical necessity for treatments like anticholinergics or Botox. |
| β | βCode Alsoβ OAB. Always check if the provider documented βOveractive Bladder.β ICD-10-CM guidelines for N39.4- dictate you should code N32.81 in addition to the incontinence code if OAB is the underlying functional driver. |
| β | Verify Medical Necessity for Botox/InterStim. Commercial payers and Medicare strictly monitor the use of 52287 (Botox) and sacral neuromodulation codes. The medical record must explicitly state that the urge incontinence (N39.41) has failed conservative behavioral therapies and at least 1-2 classes of medications (anticholinergics/beta-3 agonists) before these procedures are deemed medically necessary. |
π Sources
1. CMS/NCHS. *ICD-10-CM Official Guidelines for Coding and Reporting, FY2026.* Tabular List instructions for N39.4-.2. American Urological Association (AUA) / Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU). *Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline.*
3. Lightner, D. J., et al. (2019). Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. *Journal of Urology*, 202(3), 558-563. *(Source for treatment pathways and definitions).*
4. CMS/Medicare Administrative Contractors (MACs). *Local Coverage Determinations (LCD) for Botulinum Toxins and Sacral Nerve Stimulation.*
5. American Medical Association (AMA). *CPT Professional Edition 2026.* Surgery / Urinary System Guidelines.
Crystal's Coder Hub